Shijiazhuang Yiling Pharmaceutical: Investor Relations Activity Schedule for April 28, 2024
Shijiazhuang Yiling Pharmaceutical: Special opinion of the board of directors of Eling Pharmaceutical on the evaluation of the independence of independent directors
Shijiazhuang Yiling Pharmaceutical: Announcement of daily related transactions in 2024
Shijiazhuang Yiling Pharmaceutical: Announcement of Board Resolutions
Shijiazhuang Yiling Pharmaceutical: 2023 Annual Audit Report
Shijiazhuang Yiling Pharmaceutical: Annual Verification Report on the Use of Raised Funds
Shijiazhuang Yiling Pharmaceutical: 2023 Independent Director Debriefing Report (Chen Gang)
Shijiazhuang Yiling Pharmaceutical: Special instructions on the use of funds raised in the year
Shijiazhuang Yiling Pharmaceutical: 2024 First Quarter Report
Shijiazhuang Yiling Pharmaceutical: 2023 Annual Report Summary
Shijiazhuang Yiling Pharmaceutical: Internal Control Self-Assessment Report
Shijiazhuang Yiling Pharmaceutical: Report on the work of the Board of Supervisors for the year 2023
Shijiazhuang Yiling Pharmaceutical: Announcement on the Appointment of the 2024 Financial and Internal Control Audit Institution
Shijiazhuang Yiling Pharmaceutical: Report of the Audit Committee of the Board of Directors of Eling Pharmaceutical on the evaluation of the performance of accounting firms in 2023 and the performance of supervisory duties
Shijiazhuang Yiling Pharmaceutical: The Board's Special Opinions on Evaluating the Independence of Independent Directors
Shijiazhuang Yiling Pharmaceutical: 2023 ANNUAL REPORT
Shijiazhuang Yiling Pharmaceutical: Eling Pharmaceutical's shareholder return plan for the next three years (2024-2026)
Shijiazhuang Yiling Pharmaceutical: Internal Control Audit Report
Shijiazhuang Yiling Pharmaceutical: Annual special audit report on the expenditure of related parties' funds
Shijiazhuang Yiling Pharmaceutical: 2023 Social Responsibility Report
No Data